Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma
Authors:
- Feng-Yuan LiuFLFeng-Yuan Liu
- Angel ChaoACAngel Chao
- Chyong-Huey LaiChyong-Huey Lai
- Hung-Hsueh ChouHCHung-Hsueh Chou
- Tzu-Chen YenTYTzu-Chen Yen
- 1 June 2012
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 125 (3) , 566-571
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancerGynecologic Oncology, 2011
- Surgical cytoreduction in stage IV endometrioid endometrial carcinomaGynecologic Oncology, 2011
- Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center studyGynecologic Oncology, 2010
- Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Role of cytoreduction in stage III and IV uterine papillary serous carcinomaGynecologic Oncology, 2007
- Prognostic Factors for Uterine Cancer in Reproductive-Aged WomenObstetrics & Gynecology, 2007
- Hormonal therapy of endometrial cancerEuropean Journal of Cancer, 2005
- Stage IVB Endometrial Carcinoma: The Role of Cytoreductive Surgery and Determinants of SurvivalGynecologic Oncology, 2000
- Endometrial CarcinomaNew England Journal of Medicine, 1996